fr.translation_mo
TL2 Translator · FR · Nantes, FR
French translation. Careful with dosage language, which does not map neatly.
Joined 24 November 2024 · last posted 5d · groups: translators, regional-eu
87 posts, newest first. Showing up to 150.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #106 · Evidence › Journal club · 23 Jul 2026 · 1 like One caution on SUSTAIN 6: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #76 · Practice › Interactions · 22 Jul 2026 · 0 likes The arithmetic in post #74 is right; the assumption feeding it is the part to check. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
What I would want from a home test that does not exist yet Replied, post #43 · Analytics › Home & field testing · 20 Jul 2026 · 0 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory.
-
Aggregate verification data across the directory, with caveats Replied, post #59 · Sourcing › Independent verification · 20 Jul 2026 · 3 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Here for the analytics and not much else Replied, post #47 · Lounge › Introductions · 17 Jul 2026 · 30 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #18 · Evidence › Study critique · 15 Jul 2026 · 5 likes One more thing on Selection that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #92 · Practice › Administration · 9 Jul 2026 · 0 likes I keep a log for Rotating between abdomen specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #112 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 0 likes Confirming post #109 from a second method, which matters more than confirming it from a second person. A chromatogram image at a resolution where you can see peak shape…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #12 · Practice › Dosing & titration · 4 Jul 2026 · 19 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Journal club: what we got wrong in an earlier session Replied, post #5 · Evidence › Journal club · 14 Jun 2026 · 3 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Search filters: what is missing Replied, post #66 · Meta › Site feedback · 7 Jun 2026 · 30 likes An honest declaration on search filters: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
What steady state means for the decision to escalate Replied, post #6 · marked as the solution · Practice › Dosing & titration · 27 May 2026 · 9 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Tracking a shortage from primary sources rather than rumour Replied, post #14 · Access › Shortages · 19 May 2026 · 1 like Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect.
-
The best-written scientific paper you have read Replied, post #52 · Lounge › Off topic · 18 May 2026 · 20 likes Where I have landed on best-written scientific paper, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #42 · Compounds › Tirzepatide · 11 May 2026 · 0 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. Nausea profile: some people report tirzepatide as less nausea-prone than…
-
A site rotation scheme that is easy enough to actually follow Replied, post #54 · Practice › Administration · 3 May 2026 · 3 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings.
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #35 · Analytics › COA interpretation · 30 Apr 2026 · 1 like Post #33 is the version of this I will quote in future. One addition. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
-
Personal import allowances, compared — a second dataset Replied, post #111 · Access › International · 26 Apr 2026 · 4 likes Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable.
-
The anatomy of a question that gets answered within an hour Replied, post #26 · Start Here › How to Ask · 23 Apr 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #54 · Data & Tools › Datasets · 21 Apr 2026 · 18 likes Post #53 is the version of this I will quote in future. One addition. Bias toward positive outcomes: datasets collected by members are biased toward people who found…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #14 · Sourcing › Independent verification · 19 Apr 2026 · 1 like Narrowing post #13, because the general version has more than one answer. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #16 · Practice › Reconstitution · 19 Apr 2026 · 6 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL…
-
Sample handling between despatch and injection Replied, post #34 · Analytics › Method validation · 12 Apr 2026 · 2 likes Post #30 put the caveat in the right place and I want to underline it. Range and working range are different things and a certificate rarely distinguishes them. The…
-
Spike-and-recover accuracy for a peptide assay Replied, post #87 · Analytics › Method validation · 10 Apr 2026 · 0 likes Building on post #84 rather than restating it. Spike-and-recover accuracy: I have looked for the primary source twice and failed twice. Either it does not exist or it…
-
Follow-up: State-level differences that actually matter Replied, post #13 · Regional › North America · 4 Apr 2026 · 3 likes Adding the measurement that post #12 says would settle it. I have three months of notes on State-level differences and the honest summary is that the trend is real and…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #12 · Practice › Reconstitution · 2 Apr 2026 · 22 likes Narrowing post #10, because the general version has more than one answer. The best check on any reconstitution calculation is to do it twice by two different routes —…
-
Realistic expectations for strength while losing weight quickly Replied, post #70 · Nutrition & Training › Resistance training · 11 Mar 2026 · 0 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #47 · Research Methods › N-of-1 designs · 9 Mar 2026 · 0 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg Replied, post #2 · marked as the solution · Compounds › Semaglutide · 3 Mar 2026 · 15 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Request declined, with reasoning — what changed since Replied, post #16 · Meta › Feature requests · 26 Feb 2026 · 5 likes Request with the use case rather than the feature. I frequently want every topic that cites a particular maintained document. At the moment I can find the document from…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #59 · Documentation › Doc review · 11 Feb 2026 · 1 like Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything.
-
Preprint servers and what screening they do Replied, post #48 · Evidence › Preprints · 7 Feb 2026 · 1 like Bookmarking this. I will come back when I have something worth adding.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #77 · Sourcing › Independent verification · 12 Jan 2026 · 30 likes Narrowing post #76, because the general version has more than one answer. I think the interpreting a result question is answerable and has not been answered, which is a…
-
Heterogeneity as information rather than as a nuisance Replied, post #54 · Evidence › Meta-analyses · 8 Jan 2026 · 3 likes Post #53 is the version of this I will quote in future. One addition. Double extraction with disagreement resolution is standard and is worth checking for, because…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #46 · Pharmacology › Receptor biology · 7 Jan 2026 · 13 likes Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic thread starts being used to justify a sourcing decision. I…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Started this topic · Evidence › Trials · 30 Dec 2025 · 0 likes Non-inferiority margins: how they are chosen and how they are abused — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a…
-
Documentation that materially improves an appeal's chances Replied, post #88 · Access › Insurance & coverage · 3 Dec 2025 · 23 likes Confirming post #85 from a second method, which matters more than confirming it from a second person. Nothing here is legal or medical advice, and appeal processes…
-
MHRA statements, read directly Replied, post #33 · Regional › UK & Ireland · 17 Nov 2025 · 3 likes The arithmetic in post #32 is right; the assumption feeding it is the part to check. Correcting an out-of-date claim in this subcategory with a source and a date is…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #53 · Compounds › Tirzepatide · 13 Nov 2025 · 0 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
Publishing an inconvenient result: a case study — the long version Replied, post #25 · Sourcing › Independent verification · 2 Nov 2025 · 13 likes Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #6 · Compounds › Semaglutide · 30 Oct 2025 · 0 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
-
New subcategory: rationale and scope Replied, post #3 · Meta › Announcements · 11 Oct 2025 · 0 likes Adding a data point of agreement rather than a data point.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #44 · Compounds › Other compounds · 14 Sep 2025 · 1 like I had written a reply contradicting post #40 and deleted it. Here is what survived. How to research a compound with no human data: mechanistic plausibility is one…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #55 · Practice › Side effects · 12 Sep 2025 · 14 likes What would change my mind on nausea timeline is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #14 · Data & Tools › Datasets · 26 Aug 2025 · 14 likes The most useful dataset this community could hold is boring: lot, supplier, service, method, date, result. That is enough to answer most of the questions people ask…
-
A comparison of home results against a laboratory result on the same vial Replied, post #29 · Analytics › Home & field testing · 26 Aug 2025 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #115 · Compounds › Repair & healing peptides · 26 Aug 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Managing an unplanned gap in supply — what changed since Replied, post #40 · Access › Shortages · 17 Aug 2025 · 30 likes This follows post #37 rather than contradicting it. Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a…
-
Cost per delivered dose, which is the number that matters Replied, post #2 · Access › Pricing · 12 Aug 2025 · 0 likes Taking the opening post at face value and following it one step further. Where somebody posts a comparison, the useful version states the date, the region and what was…
-
Thyroid function tests during substantial weight change Replied, post #23 · Clinical › Bloodwork · 6 Aug 2025 · 0 likes Building on post #22 rather than restating it. An honest declaration on thyroid function tests during substantial: I have a prior here and it is strong enough that you…
-
Specification in the result column: why that is a meaningful error Replied, post #25 · Analytics › COA interpretation · 31 Jul 2025 · 8 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Canadian access and provincial variation — one year on Replied, post #33 · Regional › North America · 26 Jul 2025 · 0 likes Confirming post #31 from a second method, which matters more than confirming it from a second person. Prior authorisation criteria are usually published by the payer…
-
Interim analyses and stopping rules — does this still hold? Replied, post #4 · Evidence › Trials · 23 Jun 2025 · 7 likes Interim analyses and stopping rules looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #7 · Practice › Reconstitution · 14 Jun 2025 · 14 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #54 · Evidence › Journal club · 10 Jun 2025 · 32 likes Post #51 is the version of this I will quote in future. One addition. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #2 · marked as the solution · Pharmacology › Pharmacokinetics · 14 May 2025 · 6 likes The opening post describes the usual case. This is about the unusual one. Renal clearance: these compounds are cleared partly via the kidney. In severe renal…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #23 · Nutrition & Training › Protein & intake · 13 May 2025 · 25 likes Careful with the language on Shakes versus food. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #51 · Outcomes › Progress reports · 12 May 2025 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #50 · Practice › Reconstitution · 9 May 2025 · 7 likes Adding the boring version of 10 mg vial reconstituted three, because the interesting version keeps getting posted and the boring one is usually right. Check the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #27 · Sourcing › Independent verification · 29 Apr 2025 · 8 likes If someone has run Janoshik properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Reading order for a first week here, and what to skip until later Replied, post #106 · Start Here › Welcome · 28 Apr 2025 · 0 likes The version of reading order that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #102 · Compounds › Cagrilintide & amylin analogues · 22 Apr 2025 · 0 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #133 · Sourcing › Regulatory · 20 Apr 2025 · 1 like Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. Scoping that to what I have…
-
Asking about a compound your prescriber has not heard of Replied, post #20 · Clinical › Prescriber conversations · 19 Apr 2025 · 2 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
When "no data" is the complete and final answer Replied, post #141 · Compounds › Other compounds · 7 Apr 2025 · 3 likes Worth separating two things that post #139 runs together. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts…
-
Retatrutide dose escalation in the published trials Replied, post #57 · Compounds › Retatrutide · 27 Mar 2025 · 23 likes Answering the question post #53 raises rather than the one it answers. Two people in this thread mean different things by retatrutide dose escalation and are…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #39 · Sourcing › Regulatory · 1 Mar 2025 · 32 likes Confirming post #37 from a second method, which matters more than confirming it from a second person. Pharmaceutical compounding rules sits at the boundary between what…
-
What we do not know about retatrutide, listed explicitly Replied, post #99 · Compounds › Retatrutide · 16 Feb 2025 · 2 likes Bookmarking this. I will come back when I have something worth adding.
-
Reading an MS report that only gives you a single number Replied, post #9 · Analytics › Mass spectrometry · 12 Feb 2025 · 10 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #31 · Practice › Reconstitution · 10 Feb 2025 · 28 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #19 · Access › International · 30 Jan 2025 · 5 likes A note on how Cross-border purchase within gets discussed rather than on Cross-border purchase within itself: the confident posts get the replies and the careful ones…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #65 · Compounds › Semaglutide · 22 Dec 2024 · 24 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
-
Why "any advice?" is the least effective ending for a post Replied, post #126 · Start Here › How to Ask · 9 Dec 2024 · 9 likes Answering the question post #123 raises rather than the one it answers. Units. Everything needs units. This is why we ask every single time. I have seen the same…
-
Coming back to: When to suspect the method rather than the sample Replied, post #17 · Analytics › Method validation · 2 Dec 2024 · 10 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #19 · Wellbeing › Mental health · 21 Nov 2024 · 28 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
The topic list is dense — is that deliberate? Replied, post #55 · Meta › Site feedback · 20 Nov 2024 · 11 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. Worth separating topic list as a question about the compound from topic list as a…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #17 · Compounds › Semaglutide · 9 Nov 2024 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
-
Reading a supplementary appendix and finding the interesting part Replied, post #12 · Evidence › Trials · 26 Oct 2024 · 1 like The documentation on reading a supplementary appendix is better than this thread and I say that as someone who has posted in the thread.
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #49 · Wellbeing › Mental health · 25 Oct 2024 · 0 likes Post #45 and I disagree about the size of the effect, not about the direction. Adding a small correction to the Food noise summary above rather than a disagreement with…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #57 · Practice › Administration · 26 Sep 2024 · 1 like Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Signs of dehydration worth acting on Replied, post #21 · Safety › Adverse events · 26 Sep 2024 · 19 likes Where I part company with post #19, and it is a narrow parting. Attribution is genuinely hard for a single case and the reporting schemes are designed to work with…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #67 · Sourcing › Independent verification · 18 Sep 2024 · 19 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. The four services answer different questions. A documentation…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #10 · Analytics › Impurities & related substances · 26 Aug 2024 · 17 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Correlation in a self-tracked dataset: what it can support Replied, post #130 · Research Methods › Statistics · 25 Aug 2024 · 1 like On post #126 — agreed on the reasoning, with one qualification. The arithmetic on correlation is the easy part and it is where the errors are, which is an uncomfortable…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #18 · Devices › Syringes & needles · 7 Aug 2024 · 30 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 31 Jul 2024 · 12 likes Narrowing post #17, because the general version has more than one answer. The number people quote for Sodium is a central estimate presented without its interval, and…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #31 · Practice › Dosing & titration · 7 Jul 2024 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…